Scott Chouinard
Comptroller/Controller/Auditor bij FORRESTER RESEARCH, INC.
Vermogen: 171 919 $ op 31-03-2024
Profiel
Scott R.
Chouinard is currently working as the Treasurer & Chief Accounting Officer at Forrester Research, Inc. He previously worked as a Controller at EPIX Pharmaceuticals, Inc. Mr. Chouinard completed his undergraduate degree at Merrimack College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
FORRESTER RESEARCH, INC.
0.04% | 01-03-2024 | 7 974 ( 0.04% ) | 171 919 $ | 31-03-2024 |
Actieve functies van Scott Chouinard
| Bedrijven | Functie | Begin |
|---|---|---|
| FORRESTER RESEARCH, INC. | Comptroller/Controller/Auditor | 19-11-2009 |
Eerdere bekende functies van Scott Chouinard
| Bedrijven | Functie | Einde |
|---|---|---|
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Comptroller/Controller/Auditor | - |
Opleiding van Scott Chouinard
| Merrimack College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FORRESTER RESEARCH, INC. | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
